An investigation for investors in Gilead Sciences, Inc. (NASDAQ:GILD) shares over potential securities laws violations by Gilead Sciences, Inc. was announced and NASDAQ:GILD stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 06/01/2016 --An investigation was announced for investors of Gilead Sciences, Inc. over potential securities laws violations by Gilead Sciences in connection certain financial statements.

Investors who purchased shares of Gilead Sciences, Inc. (NASDAQ:GILD)have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779–1554.

The investigation by a law firm focuses on whether a series of statements by Gilead Sciences, regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On May 27, 2016,it was reported that Gilead Sciences, Inc had received a subpoena from the U.S. Attorney for the District of Massachusetts, initially disclosed in the Company's 10-Q for the quarter ended March 31, 2016, seeking documents related to the Company's relationship with certain nonprofits that provide financial assistance to patients. Shares of Gilead Sciences, Inc. (NASDAQ:GILD) closed on May 27, 2016, at $85.82 per share.

Those who purchased shares of Gilead Sciences, Inc. have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com